Condition
Stroke Prevention in Patients With Atrial Fibrillation clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Stroke Prevention in Patients With Atrial Fibrillation clinical trials that are recruiting, at sites in 6 countries (most in Belgium (1), Croatia (1), France (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 6Countries
All recruiting trials (2)
-
Tailored lower‑intensity blood thinner plan after left atrial appendage closure to prevent stroke
This project tests whether people with non‑valvular atrial fibrillation who get a left atrial appendage closure can stop blood thinners after taking low‑dose apixaban (2.5 mg twice daily) for 3 months, compared with people who stay on standard‑dose DOACs.
-
Concomitant Pulsed Field Ablation and Left Atrial Appendage Closure in AF Patients
In patients with atrial fibrillation who need both ablation and left atrial appendage closure, this study tests doing both procedures in a single intervention using FARAPULSE PFA and a WATCHMAN FLX device.
Related topics
Quick answers
How many Stroke Prevention in Patients With Atrial Fibrillation clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Belgium (1 trial), Croatia (1 trial), France (1 trial), Italy (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.